Cephalon signs convertible take note subscription contract with ChemGenex Pharmaceuticals Today, Cephalon, Inc. announced the signing of a convertible notice subscription contract with ChemGenex Pharmaceuticals Limited , an Australian-based oncology concentrated biopharmaceutical company.50 per share natural way .S. Food and Drug Administration for omacetaxine for the treatment of persistent myelogenous leukemia sufferers who have failed two or more tyrosine kinase inhibitor .V. And Merck Sante S.A.S.9 % of ChemGenex’s outstanding shares at A$0.70 per share.
Centralized network might reduce inappropriate packed prescriptions By Sarah Guy, medwireNews Reporter Implementing a centralized network that links province-wide pharmacy and medical center data could reduce the amount of inappropriate filled prescriptions, display Canadian study outcomes. The researchers survey a dramatic fall in the number of inappropriate packed prescriptions for opioids and benzodiazepines within 6 months of PharmaNet – a centralized prescription network including up-to-date prescription information for all occupants – getting instigated in British Columbia. Also modest reductions in inappropriate prescriptions are clinically meaningful, state Colin Dormuth and colleagues in the Canadian Medical Association Journal. Related StoriesStudy: Post medical center syndrome is usually significant risk factor for sufferers undergoing elective surgeryLoyola Medication, Palos Community Hospital jointly release innovative telemedicine programPatients offered animal-assisted therapy at UCLA Wellness If our findings could be generalized to additional jurisdictions, we estimate that such networks could eliminate millions of inappropriate filled prescriptions in the United States and Canada annually, they add. The group investigated the change in rates of inappropriate filled prescriptions of opioids and benzodiazepines – controlled chemicals that are particularly prone to misuse or resale – using data from 30 weeks preceding and 30 weeks after the implementation of PharmaNet. Over 1.3 million prescriptions were filled by 86,704 individuals for opioids during the data period, and over 1.4 million prescriptions for benzodiazepine were filled by 47,983 patients. Dormuth and co-employees defined inappropriate loaded prescriptions as those packed by patients who had already been prescribed, and had packed, a prescription for the same medication from a different physician dispensed at a different pharmacy, within seven days of the initial prescription. In all, 3.2 percent of opioid and 1.2 percent of benzodiazepine prescriptions were deemed inappropriately filled during the 30 months before PharmaNet, note the researchers. After its implementation, there was a 32.8 percent relative reduction in inappropriate prescriptions for opioids and a 48.6 percent reduction in inappropriate prescriptions for benzodiazepines, they observe. These translate to typical absolute reductions of 1 1.08 percent and 0.49 percent, respectively. The finding followed the same craze when the cohort comprised just residents aged 65 years or older, with estimated relative reductions for benzodiazepines and opioids of 0.28 percent and 0.05 percent, respectively. These results provide empirical evidence that centralized prescription systems can decrease inappropriate prescribing and dispensing of prescriptions by offering healthcare professionals real-time usage of prescription data, conclude Dormuth and team. Licensed from medwireNews with authorization from Springer Health care Ltd. All rights reserved. Neither of the ongoing celebrations endorse or recommend any commercial products, services, or equipment.